Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takako Inoue

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Respiratory Medicine Case Reports|August 4, 2015
Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigotsFumio Imamura, Norio Okamoto, Takako Inoue, et al.
Oncotarget|October 7, 2016
Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatmentFumio Imamura, Junji Uchida, Yoji Kukita, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2024
Clinical application of the Lung Cancer Compact Panel<sup>TM</sup> using various types of cytological specimens in patients with lung cancerKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Scientific Reports|December 10, 2016
Transient appearance of circulating tumor DNA associated with de novo treatmentKikuya Kato, Junji Uchida, Yoji Kukita, et al.
Investigational New Drugs|June 3, 2022
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case reportKei Kunimasa, Naotoshi Sugimoto, Motohiro Tamiya, et al.
Cancer Science|December 19, 2015
Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatmentJunji Uchida, Fumio Imamura, Yoji Kukita, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancerFumio Imamura, Junji Uchida, Yoji Kukita, et al.
Japanese Journal of Infectious Diseases|March 2, 2018
Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA<sup>+</sup>-M2BP) in Chronic Hepatitis C with Advanced FibrosisTakako Inoue, Yuji Tsuzuki, Etsuko Iio, et al.
Scientific Reports|July 7, 2016
Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patientsKikuya Kato, Junji Uchida, Yoji Kukita, et al.
Case Reports in Oncology|April 3, 2025
Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case ReportKiyohide Komuta, Kei Kunimasa, Akito Miyazaki, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Respiratory Medicine Case Reports|August 4, 2015
Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigotsFumio Imamura, Norio Okamoto, Takako Inoue, et al.
Oncotarget|October 7, 2016
Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatmentFumio Imamura, Junji Uchida, Yoji Kukita, et al.
Lung Cancer (Amsterdam, Netherlands)|February 7, 2024
Clinical application of the Lung Cancer Compact Panel<sup>TM</sup> using various types of cytological specimens in patients with lung cancerKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Scientific Reports|December 10, 2016
Transient appearance of circulating tumor DNA associated with de novo treatmentKikuya Kato, Junji Uchida, Yoji Kukita, et al.
Investigational New Drugs|June 3, 2022
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case reportKei Kunimasa, Naotoshi Sugimoto, Motohiro Tamiya, et al.
Cancer Science|December 19, 2015
Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatmentJunji Uchida, Fumio Imamura, Yoji Kukita, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2016
Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancerFumio Imamura, Junji Uchida, Yoji Kukita, et al.
Japanese Journal of Infectious Diseases|March 2, 2018
Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA<sup>+</sup>-M2BP) in Chronic Hepatitis C with Advanced FibrosisTakako Inoue, Yuji Tsuzuki, Etsuko Iio, et al.
Scientific Reports|July 7, 2016
Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patientsKikuya Kato, Junji Uchida, Yoji Kukita, et al.
Case Reports in Oncology|April 3, 2025
Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case ReportKiyohide Komuta, Kei Kunimasa, Akito Miyazaki, et al.
Pageof 15